CUBE Aerium C:68 SLT First Look

F-Prime portfolio companies have seen more than 28 products and drugs approved by regulatory agencies worldwide. Our team of investors, engineers, doctors and scientists is committed to bringing the insight, domain expertise and relationships required to help our companies make a transformational impact. The company emerged from stealth mode with substantial Series A financing backed by founding investor Omega Funds with the participation of F-Prime Capital. Aerium was seeded and incubated by Omega Funds in 2021 and started in collaboration with its two scientific founders, Dr. Giuseppe Pantaleo and Dr. Didier Trono in Switzerland.

Dr. Honig held several senior level positions in FDA’s Center for Drug Evaluation and Research and was the first Director of the Office of Drug Safety. He is a past President of American Society of Clinical Pharmacology and Therapeutics and is former PhRMA representative to the International Conference on Harmonization Management Committee. Dr. Bhuyan is joining Aerium as the Chief Medical Officer and a member of the executive team. He previously served as Vice President, Head of Clinical Development for Infectious Disease at AstraZeneca.

The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. Founded in 2004, Omega Funds is a leading international venture capital firm that creates and invests in life sciences companies that target our world’s most urgent medical needs. Omega focuses on identifying and supporting companies through value inflection points across the full arc of innovation, from company formation through clinical milestones and commercial adoption. Omega Funds’ portfolio companies have brought 47 products to market in multiple therapeutic areas, including oncology, rare diseases, precision medicine and others.

Former Takeda vaccine chief to lead new COVID antiviral venture Aerium

He has more than 20 years of experience within academia and industry notably leading clinical development of multiple established vaccines with indications spanning from neonates to older adults and special populations. Dr. Bhuyan most recently oversaw AstraZeneca’s COVID-19, RSV, Influenza and other programs which led to EUA and licensures covering 170+ countries for Vaxzevria , EUAs for Evusheld , and positive pivotal results in three trials supporting a best-in-class RSV mAb. He previously held key leadership roles in vaccines and clinical development at Pfizer, Inovio Pharmaceuticals and Merck where he has led the advancement of programs to Phase 3 and licensure. He notably led the US licensure studies of Trumenba and authored the Phase 3 development of Vaxelis . Dr. Bhuyan is an Adjunct Assistant Professor of Medicine and Infectious Diseases at the University of Pennsylvania where he completed a fellowship in Infectious Diseases.

• Dr. Ramoni is a Swiss qualified Attorney-at-law specializing in advising and representing clients in the field of sports and business law.
• Doesn’t stop the high levels with the oven but the air quality recovers must faster with the AlgenAir without having to open windows this time of year.
• From 2000 to 2006 he was a research fellow at the University of Geneva, studying the molecular basis of brain function, and also acted as Sectoral Asset Management’s Chief Scientific Officer during this period.

It was shortly after that I began noticing the subtle energizing effects during my daily routines. I wake up feeling refreshed and my work from home productivity level has been noticeably boosted. Dr. Maraganore served as the founding CEO of Alnylam from 2002 to 2021, where he built and led the company from early platform research on RNA interference through global approval and commercialization of the first four RNAi therapeutic medicines.

The aerium 3.0 removes carbon dioxide and produces oxygen as effectively as 25 house plants for a fraction of the cost, time, and space. This product works synergistically with your home garden as the algae can be used as an all-natural organic fertilizer for your plants. F-Prime Capital is a global venture capital firm investing in healthcare and technology. For the past 50 years, our independent venture capital group has had the privilege of backing great entrepreneurs building groundbreaking companies. Aerium Therapeutics’ initial efforts are focused on two monoclonal antibodies that, in preclinical testing, have shown potent neutralization of important COVID-19 Variants of Concern , including Delta, Omicron and Omicron’s subvariants BA.1, BA.1.1 and BA.2.

aerium

She has over twenty years of experience in vaccine development and virology, including R&D management, product development and project management. She has worked in biologics development since 2004, with a focus on international product development, technology evaluation, and regulatory, preclinical, and clinical development strategy. Are you looking for an opportunity to make a difference in the global fight against SARS-CoV-2 and future pandemic threats?

Kai Lin, Ph.D. is joining Aerium as the Head of Research and member of the executive team. Dr. Lin has more than 20 years of antiviral drug discovery and development experience in the pharmaceutical industry that contributed to 15 INDs and two NDAs. He is known as a strong scientific leader and virology expert with extensive knowledge on many viral pathogens, including SARS-CoV-2, RSV, HBV and flaviviruses leading drug development of both small molecule and biologics .

These findings were posted today on BioRXiv and will be submitted to a peer-reviewed journal. Our lead assets are monoclonal antibodies against SARS-CoV-2 with potent neutralizing activity in the laboratory against all variants of concern identified to date, including Delta and Omicron. Called aeriums rather than terrariums because they house Tillandsia “air plants,” they are lightweight and compact, easily hung from a wall with a single nail. The top of the glass is open so that your air plant can be taken out for easy watering, allowing you to create your own perfect wall-mounted display. We continue our “Emerging Industry Leaders” month sponsored by the Sonoran Desert Institute with Carahsoft Partner, Aerium Analytics, a multi-disciplined drone solutions company based in Calgary, Alberta conducting operations across Canada and the U.S. AERIUM specializes in geospatial intelligence, data analytics, visualization and software development to clients in myriad industries.

That group includes Omicron and its sub-variants, among them the BA.2 strain that has been detected in at least 40 countries. Venture-capital firm Omega Funds has created and provided initial funding to What is Aerium Therapeutics, a biotech startup seeking to develop a broadly effective drug for Covid-19. In pre-clinical studies, the antibodies have been potent neutralisers of SARS-CoV-2 and its variants.

illustrations, and graphic elements from the world’s best designers.

Both scientists are applying their substantial expertise and research capabilities to discover new mAbs against SARS-CoV-2. Dr. Dean is the former Vice President of Discovery Research at Takeda Pharmaceuticals. She was previously Director of New Alliances at the International AIDS Vaccine Initiative, where she directed technology identification efforts across various international collaborative HIV vaccine projects.

Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. In an interview, Venkayya said he stayed at Takeda for 10 years – longer than he expected – adding that with the dengue vaccine expected to launch sometime this year, the time for a move was right. If your cat is anything like mine, you will want to keep your Aerium out of reach. The filter on top of the Aerium is very easy for cats to push in with their little murder mittens so that they can drink the Algae like an apple meow-tini. Every time we have ever needed something, they answer right away with a smile. Also, for users with more ambient light, they may find that a 30 day growth cycle works better than the 60 day option.

Aerium

As the President and CEO of AERIUM Analytics, Jordan Cicoria brings a wealth of experience and knowledge around the safe integration of drones into the airport environment. To ensure that your algae are growing as efficiently as possible, we offer a subscription service that provides fresh algae, algae food, and replacement air filters to ensure the system is low maintenance and easy to use. The subscription is based on your unique growing cycle and should be changed every 1-2 months. Introducing the world’s first natural air purifier that uses algae to clean the air we breathe.

To be clear, having separately done some work in air quality measurement, my expectations were not that this single device would make a difference in room level CO2. Perhaps it consumes CO2 equivalent to having 25 plants- that’s good but one would need to get to high hundreds to low thousands of plant-equivalents to make a human-noticeable dent in a human-occupied room. He regularly advises medium and large companies in their business https://cryptolisting.org/ activities; he notably handled numerous merger and acquisition operations for large clients, and regularly provides advise in the field of clinical trial and research collaboration agreements. In addition, he serves on the board of several companies and foundations, including the Swiss Vaccine Research Institute. He served as Managing General Partner at Sofinnova Investments since 1997 prior to joining Omega in 2021.

He said the drugs, which are currently designed to be delivered via infusion, would eventually be modified to be given as an injection in a doctor’s office every three-to-six months. The research was published on Tuesday on the preprint server BioRXiv and the company plans to submit the paper for publication in a peer-reviewed journal. Aerium, which raised an undisclosed sum in Series A financing through Omega Funds and F-Prime Capital, will be based in Boston with research and development operations in Lausanne, Switzerland. You get the Co2 eating, oxygen producing benefits of 25 house plants with out making your house look like the Rain Forest Cafe. We live in a high altitude desert environment and the Aerium has helped add quality, oxygen-rich air to our home which helps us sleep better and helps me stay focused and relaxed at my home office. So I can’t recommend the device strictly for noticeable CO2 reduction- that’s just not possible on any technical platform at the moment.

Aerium Therapeutics is dedicated to epidemic and pandemic preparedness through the discovery and development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. The Aerium Therapeutics team brings world-class scientists and biotechnology veterans together with experienced investors, with operations in Boston, MA and Lausanne, Switzerland. Aerium’s lead assets are monoclonal antibodies that show broad activity against important variants of concern of SARS-CoV-2 including Omicron and its subvariants BA.1, B.1.1 and BA.2.